Jonathon B. Cohen, MD, MS
Advertisement
Articles by Jonathon B. Cohen, MD, MS
Recommendations for treating a 68-year-old male with mantle cell lymphoma with a BTK inhibitor once he has relapsed on prior therapy.
Advertisement
Latest Updated Articles
Case Assessment: 68-Year-Old Patient With MCLMay 18th 2020
Relapsed Mantle Cell Lymphoma Treatment LandscapeMay 18th 2020
Initiating Therapy for Mantle Cell LymphomaMay 18th 2020
BTK Inhibitor Toxicities in Mantle Cell LymphomaMay 18th 2020
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Panel Votes 10-3 In Favor of RP1 Plus Nivolumab for Advanced Melanoma
2
Improving Survival, Quality of Life, and Cost-Effectiveness for Allo-HCT
3
NCCN Lists Gedatolisib Regimens as Preferred Option in HR+/HER2– Metastatic Breast Cancer
4
FDA Approves Lutetium Lu 177 Vipivotide Tetraxetan Plus ARPI in mAPMN/S Prostate Cancer
5